SOUSEIKAI is the largest and most experienced Phase 1 clinical research center in Japan with a 362 bed capacity and 5,500+ studies to date. Our capabilities include Japanese and multi-ethnic studies (Caucasian, Korean, Chinese), enabling the targeting of multiple markets simultaneously; and an extensive industry network for potential licensing/partnering access.
Leveraging our vast experience and parent Medical Group, we have been helping domestic and overseas PHARMA and CROs access both the Japanese and Global markets for over 37 years.